ArticleRevista latino-americana de enfermagem2025
Motivations, benefits, and barriers to the use of HIV pre-exposure prophylaxis based on the health belief model.
Article in Revista latino-americana de enfermagem, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
to understand the motivations, benefits, and barriers to the use of HIV pre-exposure prophylaxis. a qualitative study grounded on the Health Belief Model. Sixteen people using HIV pre-exposure prophylaxis were followed up at two Testing and Counseling Centers in a large municipality in the interior of the state of São Paulo, Brazil. Data were collected through individual audio-recorded interviews. Data analysis followed Rosenstock's Health Belief Model and Bardin's Content Analysis. susceptibility to HIV was influenced by uncertainty about partners' serology and condom failure. The severity of HIV is perceived as greater due to its incurability. Benefits include greater protection, safety, and well-being. Barriers involve difficulties in access, side effects, and social stigma. the study revealed that the motivation for using Pre-Exposure Prophylaxis was the perception of susceptibility to HIV, the severity of the disease, and benefits such as protection and psychological well-being, while barriers involved difficulties in access, complexity of the clinical protocol, and stigma. Knowing the beliefs and barriers can favor more effective interventions by the health team.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.